ArticleJournal of neuroinflammation2014

CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.

Soraya Maria Menezes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.